Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study.
Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF.
Heart Rhythm. 2022 Dec;19(12):1993-2001. doi: 10.1016/j.hrthm.2022.07.031. Epub 2022 Aug 6.
Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study.
El-Chami MF, Burke MC, Herre JM, Shah MH, Sadhu A, Niebauer MJ, Kutalek SP, Carter N, Gold MR.
Heart Rhythm. 2020 Sep;17(9):1566-1574. doi: 10.1016/j.hrthm.2020.04.036. Epub 2020 May 4.
Implantable cardioverter defibrillator lead performance: A systematic review and individual patient data Meta-analysis.
Giacopelli D, Azzolina D, Comoretto RI, Quartieri F, Rovaris G, Schillaci V, Gargaro A, Gregori D.
Int J Cardiol. 2023 Feb 15;373:57-63. doi: 10.1016/j.ijcard.2022.11.048. Epub 2022 Nov 29.
Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety.
Wolf S, Götz G, Wernly B, Wild C.
ESC Heart Fail. 2023 Apr;10(2):808-823. doi: 10.1002/ehf2.14249. Epub 2022 Nov 29.
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxén J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N.
Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
Kutyifa V, Beck C, Brown MW, Cannom D, Daubert J, Estes M, Greenberg H, Goldenberg I, Hammes S, Huang D, Klein H, Knops R, Kosiborod M, Poole J, Schuger C, Singh JP, Solomon S, Wilber D, Zareba W, Moss AJ; MADIT S-ICD Executive Committee.
Am Heart J. 2017 Jul;189:158-166. doi: 10.1016/j.ahj.2017.04.014. Epub 2017 May 4.
Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD.
F SS, R H, A S, E J, S A, Z H, R N.
Curr Cardiol Rep. 2023 Sep;25(9):1029-1039. doi: 10.1007/s11886-023-01924-4. Epub 2023 Jul 24.
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR, El-Chami MF, Burke MC, Upadhyay GA, Niebauer MJ, Prutkin JM, Herre JM, Kutalek S, Dinerman JL, Knight BP, Leigh J, Lucas L, Carter N, Brisben AJ, Aasbo JD, Weiss R; S-ICD System Post Approval Study Investigators.
J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034.
The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
Barsheshet A, Vamvouris T, Goldenberg I.
Expert Rev Med Devices. 2016 Jul;13(7):627-32. doi: 10.1080/17434440.2016.1200969. Epub 2016 Jun 27.
Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle: A Randomized Trial.
Leong DP, Dokainish H, Mondésert B, Cavalli G, Khetan A, Cirne F, Baro Vila R, Klimis H, De Jesus TA, AlGhasab NS, Akbari V, Suliman A, Eltebi O, Almhri A, Ferdous T, Djuric A, Bashir J, Krahn AD, Exner DV, Philippon F, Birne DH, Joza J, Healey JS.
JACC Clin Electrophysiol. 2024 Sep;10(9):2088-2096. doi: 10.1016/j.jacep.2024.04.034. Epub 2024 Jul 10.
